CELESTAR LEXICO-SCIENCES
DEAD

Serial Number

76248470

Owner

Celestar Lexico-Sciences, Inc.

Attorney

Kaushal R. Odedra

Filing Date

Apr 25, 2001

Add to watchlist:

No watchlists yet
View on USPTO

CELESTAR LEXICO-SCIENCES Trademark

Serial Number: 76248470 • Registration: 2907497

CELESTAR LEXICO-SCIENCES is a trademark filed by Celestar Lexico-Sciences, Inc. on April 25, 2001. The trademark is classified under Class 9 (Computers & Electronics), Class 42 (Computer & Scientific). The application is currently no longer active.

Owner Contact Info

Celestar Lexico-Sciences, Inc. (6 trademarks)

D-17, Makuhari-Techno-Garden
Chiba-shi, Chiba , JP

Entity Type: 03

Trademark Details

Filing Date

April 25, 2001

Registration Date

December 7, 2004

Published for Opposition

September 14, 2004

Cancellation Date

July 8, 2011

Goods & Services

Computer programs for use in analyzing and visualizing nucleic acid, protein, and phage information and expression; for use in database management, integration and manipulation; for use in characterization of nucleic acid and protein information; for use in analyzing chemical structure and activity information; for use in acquisition and interrogation of clinical, pathological, diagnostic, genetic, genomic and biochemical data; for use in clinical trial design and management; for use in text and pattern recognition; for storage, retrieval and analysis of life sciences literature; for use in managing robot function; for use in processing toxicological and pharmacological information; for laboratory instrument control; for use in control of sample input to mass spectrometers; for use in spectral analysis; prerecorded CD-ROMs featuring databases containing life sciences information; pre-configured microprocessors for analysis and storage of life sciences information; computer programs for use in the management, storage, retrieval, and analysis for data in the discovery and development of diagnostic, prognostic, and therapeutic medical products; for use in identifying and characterizing proteins; for use in controlling mass spectrometers; for use in spectral analysis; for use in controlling affinity capture optical biosensors; for use in analyzing and characterizing plasmon resonance; for use in controlling liquid chromatography instruments; for use in analyzing chromatograms; for use in controlling microfluidics; for use in controlling single-dimension and multi-dimensional electrophoresis and visualizing and analyzing electrophoretic results; for use in protein analysis and spectral processing; for use in analyzing, managing, and visualizing nucleic acid and amino acid sequences

Medical and diagnostic services, namely, diagnosing, preventing, and predicting disease, identifying hereditary risk factors, diagnostic testing, prognostic testing, gene and protein testing, identifying physiological characteristics, establishing individual preventative programs, establishing disease treatment based on gene and protein expression and/or activity, evaluating clinical trial progress, drug monitoring and computer tracking of a patient's health progress; research services, namely, research, development, validation, testing, data analysis and product development services in the biomedical, genomic, pharmacogenomic, diagnostic, clinical trial design, and biotechnology fields; research consulting services, namely, research, development, validation, testing, data analysis, and product development services for others in the biomedical, genomic, pharmaceutical, pharmacogenomic, diagnostic, clinical trial design, and biotechnology field; computer services, namely, providing databases featuring life sciences information via global, national, and local computer networks in the fields of pharmacogenomics, diagnostics, clinical trial design and biotechnology; computer consulting services, namely, providing databases featuring life sciences information to others via global, national, and local computer networks in the fields of pharmacogenomics, diagnostics, clinical trial design and biotechnology

Filing History

CANCELLED SEC. 8 (6-YR)
Jul 8, 2011 C8..
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Jan 13, 2010 TCCA
REGISTERED-PRINCIPAL REGISTER
Dec 7, 2004 R.PR
PUBLISHED FOR OPPOSITION
Sep 14, 2004 PUBO
NOTICE OF PUBLICATION
Aug 25, 2004 NPUB
PAPER RECEIVED
May 11, 2004 MAIL
APPROVED FOR PUB - PRINCIPAL REGISTER
Apr 13, 2004 CNSA
CASE FILE IN TICRS
Mar 23, 2004 CFIT
CASE FILE IN TICRS
Mar 23, 2004 CFIT
Sec. 1(B) CLAIM DELETED
Mar 2, 2004 1.BD
CORRESPONDENCE RECEIVED IN LAW OFFICE
Mar 2, 2004 CRFA
PAPER RECEIVED
Mar 2, 2004 MAIL
INQUIRY AS TO SUSPENSION MAILED
Sep 2, 2003 CNSI
LETTER OF SUSPENSION MAILED
Feb 24, 2003 CNSL
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jan 24, 2003 CRFA
PAPER RECEIVED
Jan 24, 2003 MAIL
INQUIRY AS TO SUSPENSION MAILED
Oct 31, 2002 CNSI
LETTER OF SUSPENSION MAILED
Apr 5, 2002 CNSL
CORRESPONDENCE RECEIVED IN LAW OFFICE
Feb 8, 2002 CRFA
NON-FINAL ACTION MAILED
Aug 10, 2001 CNRT
ASSIGNED TO EXAMINER
Aug 3, 2001 DOCK